SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-16-008475
Filing Date
2016-09-29
Accepted
2016-09-29 16:10:23
Documents
4
Period of Report
2016-09-23
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20160923x8k.htm 8-K 35460
2 EX-10.1 imgn-20160923ex101794cb3.htm EX-10.1 165521
3 EX-99.1 imgn-20160923ex991a58564.htm EX-99.1 15167
4 GRAPHIC imgn20160923ex991a58564001.jpg GRAPHIC 15901
  Complete submission text file 0001558370-16-008475.txt   239453
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 161910109
SIC: 2834 Pharmaceutical Preparations